Loading…
BioAgilytix provides global pharmacokinetic, immunogenicity, biomarker, and CMC analytical services in a GxP environment across every phase and modality of drug development. The company operates laboratories in the United States, Europe, Australia, and China, employing over 1,100 staff and reporting more than 5 million tests annually.
AI named BioAgilytix from October 2025 to January 2026.